Deficiency in IL-17-committed Vγ4+ γδ T cells in a spontaneous Sox13-mutant CD45.1+ congenic mouse substrain provides protection from dermatitis

Nature Immunology

Volumn 14, Issue 6, 2013, Pages 584-592

  Gray, Elizabeth E ^a,b   Ramírez Valle, Francisco ^a,b   Xu, Ying ^a,b   Wu, Shuang ^a,b   Wu, Zhihao ^c   Karjalainen, Klaus E ^c   Cyster, Jason G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; INTERLEUKIN 17; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX13; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL EXPANSION; CELL HOMING; CELL MATURATION; CELLULAR IMMUNODEFICIENCY; CONGENIC STRAIN; CONTROLLED STUDY; GAMMA DELTA T LYMPHOCYTE; GENE MUTATION; IMMUNITY; LYMPH NODE; LYMPHOCYTE MIGRATION; MOUSE; MUTANT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD45; AUTOANTIGENS; CELLS, CULTURED; DERMATITIS; FLOW CYTOMETRY; INTERLEUKIN-17; LYMPH NODES; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, INBRED NOD; MICE, KNOCKOUT; MUTATION; PSORIASIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 84878257398     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2585     Document Type: Article

References (50)

1. Price, A.E., Reinhardt, R.L., Liang, H.E. & Locksley, R.M. Marking and quantifying IL-17A-producing cells in vivo. PLoS ONE 7, e39750 (2012).
2. Sutton, CE. et al. Interleukin-1 and IL-23 induce innate IL-17 production from yô T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331-341 (2009).
3. Roark, CL. et al. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing yô T cells. J. Immunol. 179, 5576-5583 (2007).
4. Cai, Y. et al. Pivotal role of dermal IL-17-producing yô T cells in skin infammation. Immunity 35, 596-610 (2011).
5. Mabuchi, T., Takekoshi, T. & Hwang, S.T. Epidermal CCR6+ yô T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J. Immunol. 187, 5026-5031 (2011).
6. + innate lymphocytes and yô T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122, 2252-2256 (2012).
7. Shibata, K., Yamada, H., Hara, H., Kishihara, K. & Yoshikai, Y. Resident VÔ1+ yô T cells control early infltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178, 4466-4472 (2007).
8. Cho, J.S. et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120, 1762-1773 (2010).
9. Martin, B., Hirota, K., Cua, D.J., Stockinger, B. & Veldhoen, M. Interleukin-17-producing yô T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321-330 (2009).
10. Heilig, J.S. & Tonegawa, S. Diversity of murine ygenes and expression in fetal and adult T lymphocytes. Nature 322, 836-840 (1986).
11. Havran, W.L. & Allison, J.P. Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors. Nature 335, 443-445 (1988).
12. Ito, K. et al. Different yô T-cell receptors are expressed on thymocytes at different stages of development. Proc. Natl. Acad. Sci. USA 86, 631-635 (1989).
13. Kisielow, J., Kopf, M. & Karjalainen, K. SCART scavenger receptors identify a novel subset of adult yô T cells. J. Immunol. 181, 1710-1716 (2008).
14. Haas, J.D. et al. Development of interleukin-17-producing yô T cells is restricted to a functional embryonic wave. Immunity 37, 48-59 (2012).
15. Melichar, H.J. et al. Regulation of yô versus aβ T lymphocyte differentiation by the transcription factor SOX13. Science 315, 230-233 (2007).
16. Turchinovich, G. & Hayday, A.C. Skint-1 identifes a common molecular mechanism for the development of interferon-y-secreting versus interleukin-17-secreting yô T cells. Immunity 35, 59-68 (2011).
17. Narayan, K. et al. Intrathymic programming of effector fates in three molecularly distinct yô T cell subtypes. Nat. Immunol. 13, 511-518 (2012).
18. Haas, J.D. et al. CCR6 and NK1.1 distinguish between IL-17A and IFN-y-producing yô effector T cells. Eur. J. Immunol. 39, 3488-3497 (2009).
19. Gray, E.E., Suzuki, K. & Cyster, J.G. Cutting edge: identifcation of a motile IL-17-producing yô T cell population in the dermis. J. Immunol. 186, 6091-6095 (2011).
20. Gray, E.E., Friend, S., Suzuki, K., Phan, T.G. & Cyster, J.G. Subcapsular sinus macrophage fragmentation and CD169+ bleb acquisition by closely associated IL-17-committed innate-like lymphocytes. PLoS ONE 7, e38258 (2012).
21. Shen, F.W. et al. Cloning of Ly-5 cDNA. Proc. Natl. Acad. Sci. USA 82, 7360-7363 (1985).
22. Kido, S. et al. Cloning and characterization of mouse mSox13 cDNA. Gene 208, 201-206 (1998).
23. Roose, J. et al. The Sox-13 gene: structure, promoter characterization, and chromosomal localization. Genomics 57, 301-305 (1999).
24. Brogna, S. & Wen, J. Nonsense-mediated mRNA decay (NMD) mechanisms. Nat. Struct. Mol. Biol. 16, 107-113 (2009).
25. Sumaria, N. et al. Cutaneous immunosurveillance by self-renewing dermal yô T cells. J. Exp. Med. 208, 505-518 (2011).
26. +yôT cells as fetal thymus-derived naturally occurring IL-17 producers. J. Immunol. 181, 5940-5947 (2008).
27. Michel, M.L. et al. Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing yô cells. Proc. Natl. Acad. Sci. USA 109, 17549-17554 (2012).
28. van der Fits, L. et al. Imiquimod-induced psoriasis-like skin infammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836-5845 (2009).
29. Nowotschin, S. & Hadjantonakis, A.K. Use of KikGR a photoconvertible green-to-red fuorescent protein for cell labeling and lineage analysis in ES cells and mouse embryos. BMC Dev. Biol. 9, 49 (2009).
30. Tomura, M. et al. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J. Clin. Invest. 120, 883-893 (2010).
31. Bromley, S.K., Yan, S., Tomura, M., Kanagawa, O. & Luster, A.D. Recirculating memory T cells are a unique subset of CD4+ T cells with a distinct phenotype and migratory pattern. J. Immunol. 190, 970-976 (2012).
32. Tomura, M. et al. Monitoring cellular movement in vivo with photoconvertible fuorescence protein "Kaede" transgenic mice. Proc. Natl. Acad. Sci. USA 105, 10871-10876 (2008).
33. Sallusto, F. et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29, 2037-2045 (1999).
34. Kreslavsky, T., Garbe, A.I., Krueger, A. & von Boehmer, H. T cell receptor-instructed aβ versus yô lineage commitment revealed by single-cell analysis. J. Exp. Med. 205, 1173-1186 (2008).
35. Lauritsen, J.P. et al. Marked induction of the helix-loop-helix protein Id3 promotes the yô T cell fate and renders their functional maturation Notch independent. Immunity 31, 565-575 (2009).
36. Verbeek, S. et al. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374, 70-74 (1995).
37. Yu, Q., Sharma, A., Ghosh, A. & Sen, J.M. T cell factor-1 negatively regulates expression of IL-17 family of cytokines and protects mice from experimental autoimmune encephalomyelitis. J. Immunol. 186, 3946-3952 (2011).
38. Ma, J., Wang, R., Fang, X., Ding, Y. & Sun, Z. Critical role of TCF-1 in repression of the IL-17 gene. PLoS ONE 6, e24768 (2011).
39. Do, J.S. et al. Cutting edge: spontaneous development of IL-17-producing yô T cells in the thymus occurs via a TGF-β1-dependent mechanism. J. Immunol. 184, 1675-1679 (2010).
40. Van Rhijn, I. et al. Massive, sustained yô T cell migration from the bovine skin in vivo. J. Leukoc. Biol. 81, 968-973 (2007).
41. Hedrick, M.N. et al. CCR6 is required for IL-23-induced psoriasis-like infammation in mice. J. Clin. Invest. 119, 2317-2329 (2009).
42. von Andrian, U.H. & Mempel, T.R. Homing and cellular traffc in lymph nodes. Nat. Rev. Immunol. 3, 867-878 (2003).
43. Wohler, J.E., Smith, S.S., Zinn, K.R., Bullard, D.C. & Barnum, S.R. yô T cells in EAE: early traffcking events and cytokine requirements. Eur. J. Immunol. 39, 1516-1526 (2009).
44. Gilliet, M. et al. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch. Dermatol. 140, 1490-1495 (2004).
45. Laggner, U. et al. Identifcation of a novel proinfammatory human skin-homing V y9VÔ2 T cell subset with a potential role in psoriasis. J. Immunol. 187, 2783-2793 (2011).
46. Kishihara, K. et al. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-defcient mice. Cell 74, 143-156 (1993).
47. Phan, T.G., Green, J.A., Gray, E.E., Xu, Y. & Cyster, J.G. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affnity maturation. Nat. Immunol. 10, 786-793 (2009).
48. Tortola, L. et al. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J. Clin. Invest. 122, 3965-3976 (2012).
49. Matloubian, M. et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355-360 (2004).
50. Zebedee, S.L., Barritt, D.S. & Raschke, W.C. Comparison of mouse Ly5a and Ly5b leucocyte common antigen alleles. Dev. Immunol. 1, 243-254 (1991).